Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)
Clinical trial NCT02269423 · COMPLETED
Trial details
- NCT number
- NCT02269423
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2015-08-25
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.